Back

Biomarin Pharmaceutical Stock Predictions

America's Final Republican President

Click here to see his 2024 election prediction.

Sell

BMRN
Biomarin Pharmaceutical

Last Price:

83.34

Seasonality Move:

6.56%

7 Day Trial

ALL ACCESS PASS

$ 7

Election Shock on August 19th?

Click here now to see the evidence I've gathered.

Biomarin Pharmaceutical Stock Forecast

Over the next 52 weeks, Biomarin Pharmaceutical has on average historically risen by 17% based on the past 24 years of stock performance.
Biomarin Pharmaceutical has risen higher in 14 of those 24 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.33%
Is Biomarin Pharmaceutical Stock Undervalued?
The current Biomarin Pharmaceutical [BMRN] share price is $80.76. The Score for BMRN is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
BMRN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Biomarin Pharmaceutical Stock Go Up Next Year?

Over the next 52 weeks, Biomarin Pharmaceutical has on average historically risen by 17% based on the past 24 years of stock performance.

Biomarin Pharmaceutical Stock Rating

Sell

Biomarin Pharmaceutical (BMRN) is a Sell

Is Biomarin Pharmaceutical overpriced?

Biomarin Pharmaceutical has risen higher in 14 of those 24 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.33%

Biomarin Pharmaceutical Stock Price History

Is BMRN stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

biomarin.com

52-Week Data

52-Week High:

99.56

52-Week Low:

76.02

Prediction Charts

Market Cap:

15.33B

Price in USD:

80.76

Volume:

1.69M

Beta:

0.89

Technical Analysis

SMA50:

87.32

SMA100:

90.25

SMA200:

89.02

52-Wk Change:

-15.91%

Stock Predictions

Is Biomarin Pharmaceutical stock public?
Yes, Biomarin Pharmaceutical is a publicly traded company.
What is the Biomarin Pharmaceutical stock quote today?
The Biomarin Pharmaceutical stock price is 80.76 USD today.
How to buy Biomarin Pharmaceutical stock online?
You can buy Biomarin Pharmaceutical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Apr-11	90.99	91.46	91.59	89.33
Apr-12	91.26	92.25	93.26	91.09
Apr-15	92.58	91.52	93.36	90.96
Apr-16	90.93	90.87	91.78	90.16
Apr-17	91.14	90.47	91.53	90.02
Apr-18	90.25	90.08	91.21	89.78
Apr-19	89.67	88.63	90.18	88.29
Apr-22	89.46	89.53	89.81	88.89
Apr-23	90.03	92.04	92.22	89.93
Apr-24	92.69	91.20	93.02	91.01
Apr-25	86.26	82.17	86.78	81.00
Apr-26	82.33	80.91	83.09	80.90
Apr-29	81.65	82.13	83.85	81.44
Apr-30	81.79	80.76	81.79	80.52

Biomarin Pharmaceutical Earnings

Biomarin Pharmaceutical Earnings Report: Per Share Biomarin Pharmaceutical Earnings Q1 Q2 Q3 and Q4 last year and next year.

Biomarin Pharmaceutical Forecast Revenue Growth

Biomarin Pharmaceutical Stock Analysis: Historical quarterly revenues per share for Biomarin Pharmaceutical and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.09 per share, an increase this year of $0.83 per share, and an increase next year of $0.89 per share.

* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.